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ABSTRACT
Shallow whole-genome sequencing to infer copy
number alterations (CNAs) in the human genome
is rapidly becoming the method par excellence for
routine diagnostic use. Numerous tools exist to de-
duce aberrations from massive parallel sequencing
data, yet most are optimized for research and often
fail to redeem paramount needs in a clinical set-
ting. Optimally, a read depth-based analytical soft-
ware should be able to deal with single-end and low-
coverage data––this to make sequencing costs fea-
sible. Other important factors include runtime, ap-
plicability to a variety of analyses and overall per-
formance. We compared the most important aspect,
being normalization, across six different CNA tools,
selected for their assumed ability to satisfy the latter
needs. In conclusion, WISECONDOR, which uses a
within-sample normalization technique, undoubtedly
produced the best results concerning variance, dis-
tributional assumptions and basic ability to detect
true variations. Nonetheless, as is the case with ev-
ery tool, WISECONDOR has limitations, which arise
through its exclusiveness for non-invasive prena-
tal testing. Therefore, this work presents Wisecon-
dorX in addition, an improved WISECONDOR that en-
ables its use for varying types of applications. Wisec-
ondorX is freely available at https://github.com/
CenterForMedicalGeneticsGhent/WisecondorX.
INTRODUCTION
Recently, due to dropping sequencing costs, the anal-
ysis of copy number alterations using shallow-depth
whole-genome sequencing (sWGS) data (coverage 0.1×
to 1×) has grown into a rising practice for many ge-
netic centers (1,2). This is not surprising: in contrast to
almost-outmoded array comparative genomic hybridiza-
tion (aCGH), sWGS is cheaper, faster and has the abil-
ity to yield results at––depending on the attained sequenc-
ing depth––unrivaled levels of accuracy (3,4). The current
most important applications of sWGS include non-invasive
prenatal testing (NIPT) (5); cancer diagnostics, practiced
on e.g. liquid biopsies (LQBs) (6), effusion fluids (7), fresh
frozen tumor tissue (FFT) (8) or formalin-fixed paraffin-
embedded material (FFPE) (9); preimplantation genetic
testing (PGT) (10) and in the context of intellectual dis-
ability and congenital abnormalities, the study of congen-
ital aberrations, which is often exercised on genomic DNA
extracted from lymphocytes (gDNA) (11).
Due to its broad field of application, an abundance of
data-analysis software has been developed for sWGS (Sup-
plementary Table S1). These are commonly referred to as
depth of coverage (DOC) methods. Other categories, en-
closing assembly-based, split-read or read-pair methods,
can additionally reveal chromosomal rearrangements (12).
Nevertheless, these require higher coverage which is gener-
ally not (yet) achievable in a diagnostic context.
DOC tools usually comprise three basic steps in which
they vary: data normalization, segmentation and aberration
calling.Whilemostly subtle differences between approaches
are present in the latter two phases, normalization seems
to be the fundamental pillar for obtaining reliable results
(13). Indeed, without normalization, predicted variations
would not only reflect copy number state, but also repetitive
sequences, GC content, mappability, polymorphisms, sam-
ple quality, false computational assumptions, etc. (14–17).
Moreover, normalization directly impacts the performance
of the following phases. Below, some of the steps executed
by the majority of these software, and some alternative ap-
proaches, largely focused on normalization, are discussed.
DOC tools partition the genome in windows
All coverage-based CNA tools start by determining the
number of reads at certain loci. Naturally, these numbers
can be interpreted as measures for copy number. As sWGS
never covers the genome entirely, a reference sequence is di-
vided in larger (often non-overlapping and equally sized)
windows or bins, which do exhibit the property of whole-
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genome coverage. An important consideration is the size of
these bins: the larger they are, the more reads they will hold
and the less ‘noise’ that will be displayed by the overall out-
put. However, using larger bins comes at a price, namely a
resulting lower resolution. Since read counts follow a bino-
mial distribution, the level of Gaussian noise can be calcu-
lated in function of the coverage and bin size (18). An opti-
mal bin size, which intrinsically depends on the interest and
type of analysis, should thus be selected according to the
sequencing depth.
A large collection of normalization techniques has previously
been described
Normalization techniques can be subcategorized in three
main groups. The most basic methodology uses a set of
healthy reference samples that were subject to the same ex-
perimental procedures. Bins from this set operate as the nor-
mal diploid state, which can be exploited for normalization.
Its main disadvantage is the need for a (generally large) set
of (validated) normal reference samples. The latter can be
omitted by using one of many reference-free approaches.
These procedures tend to normalize by using known fea-
tures (such as GC content, mappability, etc.) of a human
reference genome. Nevertheless, reference-free recipes are
often described as less performant. Finally, matched case-
control methods enable discrimination between a consti-
tutional and e.g. a tumor-derived variation (19). More-
over, minor-allele frequencies can aid in predicting the true
source of such a deviation (20). Other than the inevitable
fact that multiple high-coverage samples per patient result
in various complications, these procedures are simply not
possible for e.g. NIPT and other cell-free strategies.
In this study, six techniques, selected for their diagnos-
tic ability, popularity and distinct properties (Supplemen-
tary Table S1), are extensively compared. A basic form of
reference-free normalization can be found with FREEC
(21). Here, a polynomial fit is created between bin-wise read
counts and their GC content, which serves as a normal-
ization track. Next, mappability information is used to ei-
ther filter or additionally normalize the bins. QDNAseq
(22), however, aims at simultaneously correcting GC and
mappability bias utilizing a loess fit between counts at bins
with the same combinations of GC and mappability fea-
tures. BIC-seq2 (23) states that bin size is a particularly im-
portant parameter during normalization. Here, copy num-
bers are quasi-Poisson distributed, where a generalized ad-
ditive model is used to describe their dependence on local
genomic features. BIC-seq2 does not use mappability infor-
mation to normalize equally sized bins, but instead normal-
izes uniquelymappable windows––whichmakes sense, since
equally sized bins naturally contain varying mappable posi-
tions. Hereafter, results for larger-sized windows, and thus
a desired resolution, can still be obtained by merging nor-
malized ones to a close-to desired width.
Regarding tools that necessitate pooled healthy reference
samples, cn.MOPS (24) uses a mixture of Poisson distribu-
tions, where each locus is represented by a separate gener-
ative probabilistic model created using reference and case
samples. Although this tool is actually described for deal-
ing with higher than shallow sequencing depths, we still de-
sired to evaluate it for its use of interesting concepts. An-
other tool contained in this category is CNVkit (25). In
contrast to cn.MOPS, the set of normals is used directly
to normalize corresponding bins. On top of this, some ba-
sic within-sample normalization is performed,meaning that
CNVkit intends to correct for variation introduced by ‘un-
traceable sources’, such as varying sample quality which
impacts the effect of GC bias, without the necessity to re-
sequence control samples. A rolling median technique is
adopted to normalize bins with similar GC content, repet-
itiveness and target density––the latter describing an effect
where reads are present to a fewer extent at the edges of
targeted sites, exclusively affecting whole-exome sequencing
data. Finally, WISECONDOR (26) specifically addresses
untraceable between-sample variation. Here, a reference set
is required to both normalize bins directly, using the first
three components of a principle component analysis (PCA)
(27), and for defining sets of within-sample reference bins,
each of which represent another window that is thought
to behave the same. The search for sets of within-sample
reference bins is executed by the Euclidean distance, which
scans all samples of the pooled reference. These collections
of within-sample loci handle a second round of normaliza-
tion.Doing this, if all healthy reference samples were subject
to the same experimental and computational conditions as
the cases, the need to fully understand the mechanism be-
hind the origin of any bias is eliminated.
A blacklist of chromosomal regions is used to mask uninfor-
mative loci
The human genome harbors lots of problematic repeats
such as satellites, centromeres and telomeres which impede
short-read mapping. In addition, highly variable regions,
including among others alternative haplotypes, e.g. over-
represented on chromosome 19, all complicate normaliza-
tion. That is why every CNA tool borrows the concept
of a ‘blacklist’, holding chromosomal positions of indeter-
minable copy number. For reference-free methods, this list
is frequently pre-defined (e.g. QDNAseq), while others of-
ten derive it from a reference set (e.g. WISECONDOR).
Segmentation and aberration calling result in an easy-to-
interpret output
Arriving at the final steps, the normalized and blacklisted
profiles are divided into segments, defining loci of equal
copy number. Ideally, each chromosome forms one segment
at diploid level––at least for autosomes––with the exception
of (sub)chromosomal true aberrations. The most embraced
algorithm to realize segmentation, is circular binary seg-
mentation (CBS) (28). It is inter alia adopted by QDNAseq,
cn.MOPS and CNVkit. Finally, a statistical method tries
to separate significant segments from regions classified as
normal. Most tools offer a parameter argument that allows
to be optimally tweaked for a particular type of analysis to
maximize the number of true positives, while keeping the
false positives and negatives at a minimum.
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This study analyzes two distinct types of diagnostic tests
Using 40 validation samples, each of which processed by
all tools of interest, two disparate types of diagnostic tests
were evaluated. First, larger (sub)chromosomal aberrations
can be detected in cell-free DNA (cfDNA) by NIPT at very
low coverage (0.2–0.3×). Second, gDNA extracted from
lymphocytes at higher coverage (1×) allows the discovery
of smaller subchromosomal events. In contrast to NIPT,
non-mosaic congenital variations in gDNA are expected to
be seen at discrete constitutional copy number levels other
than diploid, whereas with NIPT, the peak of a true event
is fetal fraction-dependent. We reasoned that, if a software
supplies good results on both of these types of analyses, it
seems justified to refer to it as ‘generally applicable’, as for
malignancies, deviations are typically expected to be posi-
tioned somewhere between NIPT and constitutional devia-
tions.
MATERIALS AND METHODS
Sample and bin size selection
As half of the six tools of interest require a pooled refer-
ence set, 100 exclusive healthy reference samples were se-
lected (Supplementary Table S1). Concerning test cases,
20 healthy samples and another twenty with (validated)
aberrations, annotated during routine testing, were in-
cluded (Supplementary Table S2). The analyses were per-
formed using a bin size of 30 kb, which should enable cap-
turing the 50–450 kb confirmed events for the gDNAgroup,
whereas the NIPT group is evaluated with 100 kb bins, as
all included NIPT aberrations have larger widths (at least 5
Mb).Using these bin sizes in combinationwith the acquired
sequencing depths (Supplementary Table S2), similar levels
of noise for all profiles should be obtained.
DNA isolation
For NIPT, maternal blood samples were centrifuged within
24 h of collection at 1600g for 10min at 4◦C to separate
the plasma from the blood cells. Plasma was subsequently
centrifuged at 16 000g for 10min at 4◦C. The supernatant
was transferred to a newmicrocentrifuge tube and stored at
−80◦C or −20◦C until further processing. Finally, cfDNA
was extracted from 3.5ml of plasma using the Maxwell®
RSC ccfDNA Plasma Kit (Promega) following the manu-
facturer’s instructions. For gDNA analysis, DNA was ex-
tracted from peripheral blood lymphocytes of the patients,
following standard protocols.
Library preparation and sequencing
Shallow whole-genome sequencing of cfDNA and gDNA
samples was performed using a Hiseq3000 sequencer (Illu-
mina Inc.), starting from 5 ng input of cfDNA, or 200 ng
of gDNA. For library construction of cfDNA samples, the
NEXTflex® Cell Free DNA-Seq kit (Bioo Scientific) was
used according to manufacturer’s instructions. For gDNA
samples theNEXTflex®RapidDNASequencing kit (Bioo
Scientific) was adopted. All pipetting steps were automated
on a Hamilton Star robot (Hamilton). Library concen-
trations were measured by the Qubit High-Sensitivity kit
(Thermo Fisher Scientific), and equimolar concentrations
were pooled before sequencing. The minimal number of
reads per sample was set at 10 million for cfDNA samples
and 50 million for gDNA samples.
Mapping
Although GRCh38 mapping would be recommended, our
comparative study used Bowtie2 (29) (with fast-local flag)
to map sequencing reads to human reference genome 19, as
pregenerated files for the majority of CNA tools were solely
available for GRCh37. Bamsormadup (https://github.com/
gt1/biobambam2) was deployed to generate sorted BAM
files with marked duplicates.
Validation of aberrations
Different confirmation strategies were adopted to validate
the samples of interest (Supplementary Table S3). NIPT
validation was mostly performed by amniocentesis and
chorionic villus sampling. Five of these aberrations could
not be confirmed in the fetus: these were assumed to be
mosaic and from placental origin, mostly because the ane-
uploidies were not viable or they were supported by un-
matched fetal fractions. Fetal fractions were predicted by
SeqFF (30). For gDNA, aberrations were detected by trio
analysis. Note that for this set, we could not exclude the
presence of de novo aberrations that didn’t match any of the
parents, unless they were supported by phenotype.
Study approach
A simple pipeline was employed where every tool evalu-
ated the same set of 40 test samples (Supplementary Figure
S1). Our comparisons are comprehensively based on bin-
wise log2-transformed ratios between normalized observed
and expected read counts, a measure that is calculated by
the vast majority of CNA tools. Unfortunately, some algo-
rithms blacklist these observations extremely conservative,
while others do this rather liberal. A priori, a conservative
algorithm has a higher chance to return clean data. To avoid
bias at any level, a combined mask, created by inferring the
union of all reviewed blacklists, was applied to the result-
ing ratios of the tools––this post-normalization blacklisting
ensured that there was no interference with the actual algo-
rithms. At last, CBS was executed on all profiles in order to
obtain bias-free segments. Since not all of the reviewed tools
analyze sex chromosomes, only autosomes were considered.
Tool settings, post-processing and blacklist extraction
Post-tool parsing and the actual comparative analysis were
executed by custom scripting in Python and R, respectively.
Prior to this, every tool was applied to a set of 40 test
cases. Below some of the parameter arguments and post-
processing procedures are shortly discussed.
FREEC. Using control-FREEC (v11), the read counts
were normalized by the provided GEM mappability
file (http://boevalab.com/FREEC/tutorial.html) and hg19
chromosomal sequences (and lengths). Other arguments,
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with the exception of bin size, remained untouched. Ratios
of –1 were interpreted as blacklisted loci, others were log2-
transformed to obtain the desired measure.
QDNAseq. For QDNAseq, its manual (v1.14.0) was
strictly followed: simultaneous correction for GC content
andmappability was applied, followed by outlier smoothen-
ing. Final uncovered bins were seen as blacklisted regions.
BIC-seq2. Seq files were generated using a cus-
tom script based on the author’s descriptions
(http://compbio.med.harvard.edu/BIC-seq/). Once again,
provided chromosome-wise mappability documents were
donated to the default bicseq2-norm (v0.2.4) script. Note
that BIC-seq2 does not separate the genome in equally
sized bins: whenever an observed bin size exceeded the
specified desired size by a factor 2 or more, this was
interpreted as an alternative way of blacklisting. Ratios
were obtained by dividing the observed with the expected
read counts, followed by log2 transformation.
cn.MOPS. cn.MOPS (v1.24.0) was executed according
to its R manual, using the default settings. The function
.makeLogRatios finally donated log2-scores, where black-
listed bins were defined for having an extrapolated median
ratio––these were deduced as such.
CNVkit. The batch function and -m wgs flag enable CN-
Vkit (v0.9.3) for whole-genome sequencing use. Since no
equally sized bins are used, the same blacklisting principles
as adopted for BIC-seq2 were applied.
WISECONDOR. All settings, with the exception of -
binsize at the convert and newref functions, remained de-
fault. Blacklisted positions are characterized by a ratio of
exactly zero. According toWISECONDOR’s code, the true
ratio minus one results in a default output. After correcting
for the latter, ratios were log2-transformed.
Circular binary segmentation
Autosomal CBS was executed by the DNAcopy (v1.50.1)
R package. The alpha parameter, defining a P-value cut-off
between consecutive bins for breakpoint calling, was set to
1e−5. Segments should contain at least two bins. Finally, the
mean value of corresponding bins was interpolated as the
ratio of a segment.
The median segment variance
The observed median segment variance (MSVo), a sample-
wise measure for noise, is defined as the median of a set of
variances, where each variance corresponds to the variance
of a segment. Although not truly calculated, the expected
median segment variance (MSVe) is inversely proportional
to the bin size and the read depth, as both define noise, for
which MSVo is a measure.
MSV0 ≈ MSVe ∼ 1read depth ∗ bin size
Constitutional aberration calling
The ‘default heights’ for constitutional autosomal aberra-
tions in log2 dimension are given below, expressed as a ratio
between observed and expected copy number (CN).
Deletion = log2
(
obs CN
exp CN
)
= log2
(
1
2
)
= −1
Duplication = log2
(
obs CN
exp CN
)
= log2
(
3
2
)
≈ 0.58
The boundary for constitutional aberration calling was
chosen at an arbitrary 1/3 copy number deviation from
diploid––this to capturemost true positives, while being suf-
ficiently liberal to obtain an abundance of false positives.
Deletion cutoff = log2
(
2 − 1/3
2
)
≈ −0.26
Gain cutoff = log2
(
2 + 1/3
2
)
≈ 0.22
RESULTS
Obtaining bias-free ratios using a unified blacklist
Comparing the blacklists employed by the CNA tools il-
lustrates large differences in masking stringency, support-
ing the use of a unified blacklist to sideline this origin of
bias (Supplementary Figures S2 and S3). For 100 kb win-
dows, the conservative QDNAseq noteworthy masks 14%
of the human genome, while the more liberal CNVkit and
cn.MOPS account for only 6% each. In total, the inferred
unified blacklist covers 16% of the human genome. After
applying this mask to all bin-wise log2 ratios, healthy cases,
thought to have none or few large variations, are ideally
expected to match profiles with flat log2 patterns across
all autosomes (typical autosome-wide profiles in Supple-
mentary Figure S4 for NIPT and Supplementary Figure
S5 for gDNA). In samples with aberrations however, the
true deviations ideally transcend the background noise (typ-
ical autosome-wide profiles in Supplementary Figure S6 for
NIPT and Supplementary Figure S7 for gDNA).
Noise and normality
Variance highly depends on sequencing depth. Other than
coverage, normalization algorithms might overlook main
sources of bias which could thus negatively impact desired
overall flat, normally distributed and limited noisy profiles
in healthy cases. Overall flatness and normality can be mea-
sured by deploying the profile-wide variance and the Lil-
liefors normality test, respectively (Figure 1). Since both
should be as low as possible, WISECONDOR, closely fol-
lowed by CNVkit, score best.
Concerning a sample-wise noise measure, overall vari-
ance could be biased by subtle deviations. That is why we
described a novel robustmeasure, named the (observed)me-
dian segment variance (MSVo). This measure should re-
flect its expected equivalent, the MSVe, which is propor-
tional to read depth and selected bin size (Figure 2) (Ma-
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Figure 1. The profile-wide variance versus the Lilliefors normality statistic.
The means across log-transformed variances and Lilliefors statistics are
shown. The lower left-hand corner is expected to contain the best tools ac-
cording to these measures. One observation (gDNA/cn.MOPS), seems to
desert the otherwise apparent linear relationship between both measures,
mostly caused by sample gDNA-3 (Supplementary Figure S8).
terials and Methods). Here, it’s notable that the set of su-
perior tools comprise the ones that use reference samples.
Again, WISECONDOR’s pole position is firmly followed
by runner-up CNVkit. One observation however, gDNA-3,
escapes this trend (Supplementary Figure S8): exclusively
WISECONDOR appears to normalize this sample correct.
Note that this implies an unverified assumption stating that
for this sample, WISECONDOR’s profile utmost approx-
imates reality. Nonetheless, a second similar observation,
this time with confirmed aberrations (discussed later), will
strengthen this hypothesis.
Amplitude
Asuperior normalization strategy should not arise at the ex-
pense of inferior amplitudes (defined as the absolute value
of the corresponding segment’s log2 ratio) at true devia-
tions. The amplitude measure exhibits no large differences
between the reviewed tools, with the exception of cn.MOPS
(Figure 3). WISECONDOR does not display the largest
amplitudes, yet it seems superior compared to its current
closest rival, CNVkit. Note that the highest peaks do not
necessarily present the most correct ones––indeed, it is es-
sential that an amplitude not only indicates an aberration
but also reflects its true copy number. Nevertheless, non-
mosaic congenital gDNA deletions are constitutional and
are thus expected at log2 ratios of –1, whereas duplications
are to be seen at 0.58 (the ‘default heights’ of aberrations,
Materials and Methods). Our observations seem to conse-
quently exhibit lower amplitudes, probably due to segments
Figure 2. The median segment variance. Scattered dots represent sample-
wise observations of median segment variances (MSVo). The default box-
plots clarify the underlying distributions. A solid line represents the me-
dian, whereas a dotted line indicates the mean. Note that the means are
consistently higher than the medians, caused by outlier sample gDNA-3
(Supplementary Figure S8), which is additionally marked by arrows. The
colors of the dots represent the MSVe, a measure that depends on bin size
and sequencing depth. According to the outlier sample, the lowest mean
and median MSVo and a generally smooth blue-to-yellow (MSVe) transi-
tion, WISECONDOR scores best.
with outer bins that merely cover the matching loss or gain,
an effect greatly affecting these narrow events.
Performance
Without replicating a true statistical algorithm, gDNAsam-
ples allow for a hard ratio cut-off as aberrations from non-
mosaic origin, which are not subject to tumor or fetal
fraction, are expected to appear at ‘default heights’. This
boundary was chosen at 1/3 copy number deviation from
diploid (Materials and methods)––this to capture most true
positives, while being sufficiently liberal to obtain an abun-
dance of false positives, supporting algorithm-wise compar-
ison.
Using this approach, solely CNVkit and WISECON-
DOR realize a sensitivity of 100%, where WISECONDOR
returns six false positives, while CNVkit claims 10. Remark
that these false observations could involve non-annotated
true events as well: de novo gains and losses cannot be ex-
cluded during trio-analysis. Notably, according to the reci-
procity of dots across the tools of interest, WISECON-
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Figure 3. The amplitude of aberrations. Traveling left-to-right lines sym-
bolize specific confirmed events (Supplementary Table S3) and their inter-
pretation by the tools. The default boxplots clarify the underlying distri-
butions. Solid lines (both for boxplots and observations) represent NIPT,
whereas gDNA is depicted by dotted lines. For NIPT, one sample ap-
pears with elevated amplitudes, which concerns a mosaic maternal varia-
tion (NIPT-22). The narrowest event (in gDNA-11) is exclusively captured
by cn.MOPS, CNVkit and WISECONDOR.
DOR’s false positives probably belong to this group of
unannotated narrow events (Supplementary Figure S9).
gDNA-12, a second problematic sample that seems to
suffer from unaccounted bias, provoked multiple false pos-
itive results across all tools except one (Supplementary Fig-
ure S10). In e.g. chromosome 5, true events exclusively tran-
scend the noise in WISECONDOR (Figure 4).
Finally, receiver operating characteristic (ROC) curves
enable us to truly study bin-wise performance without
a potentially biased predefined aberration cut-off. Again,
WISECONDOR performs best, with differences in gDNA
expressed to the greatest extent (Figure 5). Remember that
these curves do not represent the true performance of the
tools (which is underestimated), yet they do reflect the most
important aspect, being bin-wise normalization.
WISECONDOR’s limitations
AlthoughWISECONDORcertainly normalizes copy num-
ber data in the most consistent way, a CNA tool com-
prises more than a normalization phase. WISECONDOR
Figure 4. Chromosome 5 profile comparison of problematic sample gDNA-
12. Although exclusively cn.MOPS depicts false positives in chromosome
5, scattered segments in all but WISECONDOR’s profile indicate mosaic
deviations, which are not the case. It appears that solely WISECONDOR
accounts for a particular type of bias, highly present in this sample.
Figure 5. The performance capabilities of normalization techniques. The
gDNA plot (left) represents the performance on all gDNA cases, the NIPT
plot (right) on the remaining NIPTs. The false positive rate for gDNA is
shown in log-scale. These ROC curves do not represent the true perfor-
mance of the tools, yet they do indicate themost important aspect: normal-
ization.We can thus conclude that, for both gDNAandNIPT,WISECON-
DOR performs best. Note that the WisecondorX curves are highly similar
to the ones fromWISECONDOR, as very few modifications to the actual
normalization algorithm have been made.
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was originally introduced as a NIPT-specific data analysis
software. Suitable for debate, this implies that sex chromo-
somes are of less interest. Moreover, due to complications,
such as a gender-dependent presence or absence of fetal Y-
reads and a variable number of X-reads, gonosomes were
excluded from the analysis. WISECONDOR implements
a Stouffer’s z-score sliding window approach to simulta-
neously segment and score possible aberrations. This algo-
rithm is unfortunately extremely slow for small bin sizes: we
observed a mean runtime of 24 h for a realistic resolution
of 15 kb. Evenmore important, the algorithm is error-prone
when dealing with large amounts of deviations. Particularly
aberrations-within-aberrations cannot be dealt with and are
not segmented correctly. In conclusion, WISECONDOR
lacks basic necessities to suffice for a generally applicable
sWGS tool.
WisecondorX
In response to previous limitations, we developed Wisecon-
dorX. This novel freely available software package, written
in Python and R, contains the same normalization princi-
ples, yet combined with fundamental custom code. To im-
prove user-experience, we made WisecondorX installable
through Bioconda (31). Below, some of the main adapta-
tions are shortly introduced.
Gonosomal copy number detection. WisecondorX inter-
nally separates male from female samples, using a Gaus-
sian mixture model with two expected components, trained
on the Y-read fraction during reference creation. This tech-
nique appears to work extremely well across different types
of analyses. While all samples are still used to generate an
autosomal reference, both gender groups are treated sep-
arately to generate two additional gonosomal references.
This process does not compromise with usability: only one
reference file is generated. When evaluating a new sample,
the gender is automatically predicted and the correct gono-
somal reference is selected for normalization.
Segmentation. CBS substitutes the original iterative
Stouffer’s z-score technique. This results in both signifi-
cantly lower computing times (Figure 6) and more correct
segments for analyses beyond NIPT (Supplementary
Figure S11). Both CBS and segmental z-score calculations
(discussed below) are weighted using variability informa-
tion extracted from the reference set in WisecondorX, a
methodology based on similar key steps in CNVkit. This
way, bins with statistics that are less likely to be accurate
are down-weighted.
Bin-wise, segmental and chromosomal z-scores. Bin-wise z-
scores are calculated by treating thewithin-sample reference
sets as null distributions, as is default in WISECONDOR.
However, we believe that segmental and chromosomal z-
scores should not be influenced by other aberrations. That
is why, during reference creation, bin-wise values from 100
healthy samples (or less, depending on how many are pro-
vided) are normalized and saved in a large ‘reference ma-
trix’. During z-scoring, naturally occurring variance at any
loci, irrespective of the size, can be measured by this matrix.
Zsegment(n→m) =
μw(Rn, R..., Rm) − μ
(
μw(r1,n, r1,..., r1,m), . . . , μw(rp,n, rp,..., rp,m)
)
std (μw(r1,n, r1,..., r1,m) , . . . , μw(rp,n, rp,..., rp,m))
In the above formula, Zsegment(n→m) represents the z-score
corresponding to a segment (or chromosome) ranging from
bin n until m. μw() calculates the average of the provided
sequence weighted by bin-wise variability calculated during
reference creation. The functions μ() and std() calculate a
default mean and standard deviation, respectively. Rn rep-
resents the ratio of the studied sample at bin n, while e.g.
r2,n holds the ratio for the same locus in null case 2. There
are p healthy null cases in the reference matrix.
Figure 6. Runtime comparison between WISECONDOR and Wisecon-
dorX. Minutes are presented in logarithmic scale. Timing covered the
‘bam to result’ principle (meaning the combination of the convert and test
(WISECONDOR) or predict (WisecondorX) functions). Despite not be-
ing analyzed by this validation set, WISECONDOR exceeds a mean run-
time of 24 h for resolutions of 15 kb (supposed exponential complexity for
the test function), whereasWisecondorX barely increased with 2 min (sup-
posed linear complexity for the predict function). The increased runtime in
WISECONDOR is caused by the iterative Stouffer’s z-score procedure.
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Zsegment(n→m) represents a score that is directly propor-
tional to the ‘healthy variability’ of the corresponding lo-
cus.Moreover, the length of a segment/chromosome is con-
sidered: the means of longer segments express less natural
variability, therefore yielding higher scores for equal ratios.
We retrospectively applied this score to 5000NIPT samples,
missing not one confirmed aneuploidy, while retrieving only
few false positives, most of which concerned maternal aber-
rations.
Aberration calling. Notwithstanding z-scores are thus cal-
culated, a user-definable cut-off for aberration calling, asso-
ciated to log2 ratios, is used to separate aberrant segments
from normal ones––this to preserve the general character
of WisecondorX, where significance is unrelated to type of
analysis and interest. A key principle in diagnostics fur-
ther supports this methodology: if a small deviation from
the healthy state is observed, it should be studied, irrespec-
tive of its statistical significance. This parameter argument
is named –beta and represents the linear trade-off between
assigning aberrant to every segment (–beta 0) and to ex-
clusively expected non-mosaic variants from samples with
100% constitutional purity (–beta 1). When the tumor or
fetal fraction is known, this parameter should be optimally
close to this measure.
Output. On top of what’s listed above, numerous smaller
yet important changes in terms of interpretability and us-
ability were made. These e.g. include the user’s capability to
output various tables, which can easily be processed by any
automatic in-house diagnostic pipeline, and a basic plotter,
which intends to visualize results during stand-alone use.
For validation purposes, WisecondorX was also sub-
jected toROC comparison (Figure 5). One test case that was
not yet reviewed involved a gonosomal aneuploidy (NIPT-
21; Supplementary Table S3), where previous comparative
study exclusively considered autosomes. A genome-wide
overview of this sample, inter alia resulting from Wisecon-
dorX’s output, is shown in Supplementary Figure S12. As
anticipated, the deviation is captured.
DISCUSSION
Shallow whole-genome sequencing is rapidly becoming the
method of choice to infer copy number alterations (>10 kb)
in a diagnostic environment. This study compares the most
important aspect of computational data analysis during this
process, which is normalization, across six different CNA
tools (FREEC, QDNAseq, BIC-seq2, CNVkit, cn.MOPS
and WISECONDOR) and two types of disparate material
(cell-free DNA obtained during routine NIPT and gDNA
extracted from lymphocytes).
A unified blacklist was derived to generally mask prob-
lematic regions in the test cases, as this results in the fairest
comparison. An important consideration is that mostly
reference-freemethods (FREEC,QDNAseq and BIC-seq2)
will benefit from this procedure. Indeed, the other tools
(CNVkit, cn.MOPS and WISECONDOR) partly compile
a blacklist based on the type of analysis and laboratory
steps, as they exploit healthy reference samples of identical
material that were subject to the same experimental pro-
cedures as the test cases. The union of all blacklists con-
sequently introduces this mask to the reference-free meth-
ods. Nonetheless, this procedure seems justified as our in-
terest lies with comparing normalization, which is indepen-
dent from blacklisting. In short, we noticed that without
this supplementary mask, the differences between WISEC-
ONDOR and the other tools are pronounced to an even
greater extent, even compared to QDNAseq, which uses a
more conservative blacklist, meaning WISECONDOR se-
lects its blacklist in a well-balanced and an apparent correct
way.
A tool’s necessity for a pooled reference set might intro-
duce complications, yet these compensate beyond doubt for
the improved results. Especially in a diagnostic setting, the
focus of this paper, acquiring a set of healthy pre-analyzed
samples should not form an obstacle.Moreover, most tools,
including WISECONDOR, provide code to transform a
reference set into a compressed and directly interpretable
format, a process that should only be executed once, mean-
ing testing does generally not increase runtime in compari-
son to reference-free methods.
Two striking observations (gDNA-3 and gDNA-12) indi-
cate unknown bias that remained unaccounted in all tools
but WISECONDOR. Our institution retrospectively re-
ported numerous other such cases, at the time concluding
that, for unknown reasons, these samples could not be nor-
malized efficiently. Notwithstanding that the true source of
this bias remains unknown, WISECONDOR appears to
accurately normalize these data. To interpret this finding,
remember that both CNVkit and WISECONDOR imple-
ment the idea of within-sample normalization. ForCNVkit,
bin associations within a genome are based on genomic fea-
tures such asGC content, whereas inWISECONDOR links
arise from the Euclidean distance measure which scans all
pooled reference genomes. The latter technique circumvents
the need to fully understand the mechanism behind any
source of potential bias. We hypothesize that, as CNVkit
fails in correctly normalizing both gDNA-3 and gDNA-12,
in contrast to WISECONDOR, the bias in these samples
originates from another than typical source.
Concluding a comprehensive comparative study con-
cerning three pillars of normalization, WISECONDOR
returned the best results. In healthy cases, normally dis-
tributed, overall flat and non-noisy profiles were obtained.
Concerning performance capabilities, WISECONDOR re-
alized afresh superior outcome. These positives were not
compromised with inferior amplitudes at validated aberra-
tions.
Although WISECONDOR’s approach certainly outper-
forms the other normalization algorithms, as just described,
several limitations make it unfit for routine diagnostic use.
We concluded our paper by releasing an adapted version
of WISECONDOR, named WisecondorX, which supports
a similar normalization procedure, yet the algorithm is en-
abled for genome-wide and general use beyond NIPT.
In contrast to most other established tools,WisecondorX
does not base it aberration calls on a true underlying statis-
tical procedure. We believe these procedures can only work
reliable when they are optimized for a specific type of anal-
ysis. Indeed, a statistical approach should be optimized to
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expectance: in theory, for NIPT, as we expect none or some-
times one large deviation with a small amplitude, an algo-
rithm could measure the deviation of a segment in compar-
ison to the others, yet this reasoning does not apply for a
highly aberrant tumor sample. Furthermore, when constitu-
tional aberrations are of interest, higher amplitudes at vari-
ations are typically expected compared to cases subjected to
DNA purity/fraction such as NIPT: it’s virtually impossi-
ble to optimize a statistical recipe for all of the latter. Finally
note that in a diagnostic setting, significance levels seem
less important: an apparent variant should still be reported,
even if it did not reach a user-defined significance level. Nev-
ertheless, z-scores are still calculated by WisecondorX and
have been shown to work reliably for NIPT.
To conclude, WisecondorX has been adopted by the Vi-
Var structural genomic variation platform (32), where it re-
placed the reference-free QDNAseq software.
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